The decreasing incidence of endometrial cancer: public health implications.
- 1 January 1982
- journal article
- research article
- Published by American Public Health Association in American Journal of Public Health
- Vol. 72 (1) , 65-68
- https://doi.org/10.2105/ajph.72.1.65
Abstract
The incidence of endometrial cancer in the San Francisco area between 1969 and 1979 is compared to trends in estrogen sales and prescriptions. Both estrogen use and endometrial cancer incidence increased steadily until 1975 and then decreased significantly. The data support the previously documented association between endometrial cancer and estrogen use, but suggest that short-term usage may carry only slightly increased risk which can be eliminating entirely upon termination of therapy.This publication has 17 references indexed in Scilit:
- Risk of exogenous estrogen therapy and endometrial cancerAmerican Journal of Obstetrics and Gynecology, 1980
- Estrogen and endometrial cancer: Cases and two control groups from North CarolinaAmerican Journal of Obstetrics and Gynecology, 1980
- Endometrial cancer in relation to patterns of menopausal estrogen useJAMA, 1979
- Effects of long-term estrogen replacement therapyAmerican Journal of Obstetrics and Gynecology, 1979
- Replacement Estrogens and Endometrial CancerNew England Journal of Medicine, 1979
- Endometrial Cancer and Estrogen UseNew England Journal of Medicine, 1979
- Estrogens and Endometrial Cancer in a Retirement CommunityNew England Journal of Medicine, 1976
- Increasing Incidence of Endometrial Cancer in the United StatesNew England Journal of Medicine, 1976
- Increased Risk of Endometrial Carcinoma among Users of Conjugated EstrogensNew England Journal of Medicine, 1975
- Association of Exogenous Estrogen and Endometrial CarcinomaNew England Journal of Medicine, 1975